FREQUENCY, POTENTIAL RISK AND THERAPEUTIC INTERVENTION IN END-STAGE RENAL DISEASE PATIENTS WITH ANTIPHOSPHOLIPID ANTIBODY SYNDROME

Abstract

In conclusion, our data suggest that the patients with APAS are at high risk of posttransplant renal thrombosis. Anticoagulation therapy could prevent patients from posttransplant thrombosis in patients with APAS.